Back to Journals » OncoTargets and Therapy » Volume 11

The regulation of cytokine signaling by retinal determination gene network pathway in cancer

Authors Zheng X, Liu Q, Yi M, Qin S, Wu K

Received 4 June 2018

Accepted for publication 23 August 2018

Published 4 October 2018 Volume 2018:11 Pages 6479—6487

DOI https://doi.org/10.2147/OTT.S176113

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Manfred Beleut

Peer reviewer comments 2

Editor who approved publication: Dr Takuya Aoki


Xinhua Zheng,1,2,* Qian Liu,2,* Ming Yi,2 Shuang Qin,2 Kongming Wu2

1Department of Clinical Medicine, Medical School of Pingdingshan University, Pingdingshan, Henan 467000, China; 2Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

*These authors contributed equally to this work

Abstract: Tumor environment plays a pivotal role in determining cancer biology characteristics. Cytokine factors, as a critical component in tumor milieu, execute distinct functions in the process of tumorigenesis and progression via the autocrine or paracrine manner. The retinal determination gene network (RDGN), which mainly comprised DACH, SIX, and EYA family members, is required for the organ development in mammalian species. While the aberrant expression of RDGN is involved in the proliferation, apoptosis, angiogenesis, and metastasis of tumors via interacting with different cytokine-related signals, such as CXCL8, IL-6, TGF-β, FGF, and VEGF, in a cell- or tissue-dependent manner. Thus, joint detection of this pathway might be used as a potential biomarker for the stratification of target therapy and for the precision prediction of the prognosis of cancer patients.

Keywords: DACH1, SIX1, EYA1, cytokine, tumor, proliferation, metastasis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]